{"gene":"GABRA5","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":2018,"finding":"The de novo GABRA5 p.V294L variant produces GABAA receptors (α5β3γ2) that are ~10-fold more sensitive to GABA but exhibit reduced maximal GABA-evoked current due to increased receptor desensitization, establishing a gain-of-function mechanism contributing to early-onset epilepsy.","method":"Whole-cell patch-clamp recordings from HEK293T cells expressing recombinant α5β3γ2 GABAA receptors carrying the p.V294L substitution","journal":"Brain","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro functional reconstitution with disease-associated mutagenesis","pmids":["29961870"],"is_preprint":false},{"year":2019,"finding":"De novo GABRA5 missense variants p.V294F and p.S413F (in transmembrane domains) reduce cell-surface and total receptor expression, alter endoplasmic reticulum processing, impair synaptic clustering, reduce GABAA receptor function, and decrease GABA binding potency when incorporated into α5β3γ2 receptors.","method":"Whole-cell patch-clamp electrophysiology, immunofluorescence receptor clustering assays, and biochemical analysis of ER processing in neuronal and non-neuronal cells expressing mutant α5 subunits","journal":"Brain","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (electrophysiology, cell biology, biochemistry) in a single rigorous study","pmids":["31056671"],"is_preprint":false},{"year":2023,"finding":"GABRA5-positive neurons in the lateral hypothalamic area (LHA) polysynaptically project to brown and white adipose tissues; chemogenetic inhibition of these neurons suppresses fat thermogenesis and increases weight gain, while gene silencing of GABRA5 in LHA decreases weight gain. In diet-induced obesity, these neurons are tonically inhibited by nearby reactive astrocytes that release GABA synthesized via monoamine oxidase B (Maob).","method":"Chemogenetic (DREADD) manipulation, anterograde/retrograde tracing, gene silencing (AAV-shRNA), in vivo electrophysiology, and pharmacological inhibition of Maob in mice","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vivo approaches with defined circuit-level and metabolic phenotypes","pmids":["37653043"],"is_preprint":false},{"year":2013,"finding":"Loss of the α5 subunit gene (Gabra5-/-) in mice causes a compensatory ~40% reduction in hyperpolarization-activated cation current (Ih) and a 41% decrease in HCN1 protein expression in hippocampal neurons, indicating homeostatic co-regulation between tonic GABAergic inhibition (α5GABAA receptors) and HCN channels.","method":"Whole-cell patch-clamp recordings from cultured embryonic and ex vivo CA1 hippocampal neurons of Gabra5-/- mice; Western blot for HCN1 protein; membrane impedance measurements","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with multiple electrophysiological and biochemical readouts in two neuronal preparations","pmids":["23516534"],"is_preprint":false},{"year":2022,"finding":"POMC neuron-specific knockdown of Gabra5 in male mice increases firing frequency and resting membrane potential of POMC neurons, decreases mIPSC amplitude, and improves glucose tolerance, revealing a sexually dimorphic role of GABRA5 in GABAergic inhibitory control of POMC neurons and glucose homeostasis (effect absent in females).","method":"CRISPR-Cas9-mediated POMC-specific gene knockdown; whole-cell patch-clamp electrophysiology of POMC neurons; glucose tolerance tests in male and female mice","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — cell-type-specific KD with electrophysiological and physiological phenotypes, single study","pmids":["36120438"],"is_preprint":false},{"year":1997,"finding":"The GABRA5 gene produces three distinct mRNA isoforms in human brain differing only in the 5' UTR, arising from three alternative first exons (1A, 1B, 1C) driven by distinct promoter elements; CAT reporter assays confirmed promoter activity upstream of each first exon, with expression being tissue- and brain-region-specific.","method":"cDNA library screening, 5' RACE, Northern blot, genomic sequencing, CAT reporter assays in transfected cells","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods (RACE, Northern blot, reporter assay) in a single study establishing transcriptional regulation","pmids":["9205108"],"is_preprint":false},{"year":1997,"finding":"GABRA5 is encoded by 11 exons spanning ~86 kb on chromosome 15q11-q13, and the GABRG3 gene is located within 35 kb of GABRA5 and transcribed in the same orientation, establishing the physical organization of the GABRA5/GABRG3 cluster.","method":"Genomic contig construction (P1, lambda phage, PAC clones), exon mapping, FISH","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — direct genomic characterization with physical mapping","pmids":["9126483","7601451"],"is_preprint":false},{"year":2023,"finding":"Constitutive ablation of Gabra5 in mice leads to a hyperpolarized state of hippocampal neurons (measured by electrophysiology), suggesting compensatory upregulation of other channels or GABA receptor subunits, and is accompanied by decreased fecal corticosterone metabolites, linking GABRA5 to HPA axis activity.","method":"Whole-cell electrophysiological recordings from hippocampal neurons of Gabra5 knockout mice; fecal corticosterone metabolite measurements; behavioral testing","journal":"Genes","confidence":"Low","confidence_rationale":"Tier 3 — single study with limited mechanistic follow-up on compensation mechanism","pmids":["36833213"],"is_preprint":false}],"current_model":"GABRA5 encodes the α5 subunit of GABAA receptors, a ligand-gated chloride channel that mediates tonic GABAergic inhibition; disease-associated mutations alter receptor desensitization, surface trafficking, and GABA sensitivity, while the α5-containing receptor also engages in homeostatic co-regulation with HCN channels in hippocampal neurons and, in the lateral hypothalamus, GABRA5-positive neurons receive astrocyte-derived (MAO-B-synthesized) GABA inhibition to control adipose thermogenesis and body weight."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing the genomic architecture of GABRA5 — its 11-exon structure, chromosomal location at 15q11-q13, proximity to GABRG3, and three alternative 5′ UTR isoforms driven by distinct promoters — provided the foundational gene model and explained tissue- and brain-region-specific transcriptional regulation.","evidence":"Genomic contig construction, exon mapping, FISH, 5′ RACE, Northern blot, and CAT reporter assays in human brain and transfected cells","pmids":["9126483","7601451","9205108"],"confidence":"Medium","gaps":["Which transcription factors drive the three alternative promoters remains undefined","Protein-level confirmation of isoform-specific expression in brain subregions was not performed"]},{"year":2013,"claim":"Demonstrating that Gabra5 knockout mice exhibit compensatory downregulation of HCN1 and reduced Ih in hippocampal neurons established that α5-containing GABAA receptors and HCN channels are homeostatically co-regulated, revealing a mechanism by which tonic inhibition is coupled to intrinsic neuronal excitability.","evidence":"Whole-cell patch-clamp recordings from cultured embryonic and ex vivo CA1 hippocampal neurons of Gabra5−/− mice; Western blot for HCN1 protein","pmids":["23516534"],"confidence":"High","gaps":["The signaling pathway linking loss of α5-mediated tonic inhibition to HCN1 downregulation is unknown","Whether this co-regulation occurs in brain regions beyond hippocampus is untested"]},{"year":2018,"claim":"Functional characterization of the epilepsy-associated p.V294L variant revealed a gain-of-function mechanism — increased GABA sensitivity coupled with enhanced desensitization — providing the first direct link between a specific GABRA5 mutation and altered channel gating in disease.","evidence":"Whole-cell patch-clamp recordings from HEK293T cells expressing recombinant α5β3γ2 GABAA receptors with the p.V294L substitution","pmids":["29961870"],"confidence":"High","gaps":["In vivo neuronal consequences of V294L on network excitability were not tested","Whether enhanced desensitization leads to net loss or gain of tonic inhibition in intact circuits is unresolved"]},{"year":2019,"claim":"Characterization of additional epilepsy-associated variants (p.V294F, p.S413F) showed that transmembrane domain mutations can impair receptor biogenesis at the ER level, reduce surface expression and synaptic clustering, and decrease GABA potency, establishing loss-of-function as a second disease mechanism complementary to the gain-of-function V294L.","evidence":"Whole-cell patch-clamp electrophysiology, immunofluorescence clustering assays, and biochemical ER processing analysis in neuronal and non-neuronal cells","pmids":["31056671"],"confidence":"High","gaps":["Structural basis for differential effects of V294L versus V294F on gating versus trafficking is not resolved","Patient-derived neuronal models have not been used to validate these findings"]},{"year":2022,"claim":"POMC neuron-specific knockdown of Gabra5 increased firing rate and improved glucose tolerance in male but not female mice, revealing a sexually dimorphic metabolic role for α5-mediated inhibition in hypothalamic energy-sensing circuits.","evidence":"CRISPR-Cas9-mediated POMC-specific knockdown; patch-clamp electrophysiology of POMC neurons; glucose tolerance tests in both sexes","pmids":["36120438"],"confidence":"Medium","gaps":["Single study; independent replication is needed","Molecular basis of sex-specific effects is unexplored","Whether this reflects α5-specific tonic inhibition versus compensation by other subunits is unclear"]},{"year":2023,"claim":"Identification of GABRA5-positive lateral hypothalamic neurons that polysynaptically control adipose thermogenesis — and are tonically silenced by astrocyte-derived GABA via MAO-B in obesity — established a brain-to-fat circuit through which α5-containing receptors regulate whole-body energy expenditure.","evidence":"Chemogenetic (DREADD) manipulation, anterograde/retrograde neural tracing, AAV-shRNA gene silencing, in vivo electrophysiology, and MAO-B pharmacological inhibition in mice","pmids":["37653043"],"confidence":"High","gaps":["Whether this circuit is conserved in humans is unknown","The specific GABAA receptor subunit composition on these LHA neurons beyond α5 has not been defined","Downstream signaling from LHA GABRA5 neurons to adipose sympathetic outflow is not fully mapped"]},{"year":null,"claim":"Key unresolved questions include the structural basis for how different transmembrane domain mutations produce opposite functional outcomes (gain- versus loss-of-function), whether the α5/HCN1 homeostatic axis operates through a defined signaling intermediate, and how the metabolic functions of GABRA5 in hypothalamic circuits integrate with its well-characterized role in hippocampal tonic inhibition.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of α5-containing GABAA receptors with disease mutations","Signaling pathway linking α5-mediated tonic inhibition to HCN1 expression is undefined","Human relevance of LHA and POMC neuron GABRA5 metabolic circuits is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,1,3,4]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,1]}],"complexes":["α5β3γ2 GABAA receptor"],"partners":["GABRB3","GABRG2","HCN1"],"other_free_text":[]},"mechanistic_narrative":"GABRA5 encodes the α5 subunit of GABAA receptors, which assembles into α5β3γ2 pentameric ligand-gated chloride channels that mediate tonic GABAergic inhibition in the brain and regulate neuronal excitability, metabolic homeostasis, and adipose tissue thermogenesis. Disease-associated missense mutations in transmembrane domains (e.g., p.V294L, p.V294F, p.S413F) alter GABA sensitivity, receptor desensitization, endoplasmic reticulum processing, cell-surface trafficking, and synaptic clustering, establishing both gain- and loss-of-function mechanisms contributing to early-onset epilepsy [PMID:29961870, PMID:31056671]. Genetic ablation of Gabra5 in mice triggers homeostatic compensation including a ~40% reduction in HCN1-mediated Ih current in hippocampal neurons, demonstrating co-regulation between tonic GABAergic and hyperpolarization-activated cation conductances [PMID:23516534]. In the lateral hypothalamic area, GABRA5-positive neurons polysynaptically innervate adipose tissue to control thermogenesis and body weight, and are tonically inhibited by astrocyte-derived GABA synthesized via monoamine oxidase B during diet-induced obesity [PMID:37653043]."},"prefetch_data":{"uniprot":{"accession":"P31644","full_name":"Gamma-aminobutyric acid receptor subunit alpha-5","aliases":["GABA(A) receptor subunit alpha-5","GABAAR subunit alpha-5"],"length_aa":462,"mass_kda":52.1,"function":"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:14993607, PubMed:29961870, PubMed:30140029, PubMed:31056671). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:30140029). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the cell membrane down their electrochemical gradient (PubMed:14993607, PubMed:30140029). GABAARs containing alpha-5/GABRA5 subunits are mainly extrasynaptic and contribute to the tonic GABAergic inhibition in the hippocampus (By similarity). Extrasynaptic alpha-5-containing GABAARs in CA1 pyramidal neurons play a role in learning and memory processes (By similarity)","subcellular_location":"Postsynaptic cell membrane; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P31644/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GABRA5","classification":"Not Classified","n_dependent_lines":8,"n_total_lines":1208,"dependency_fraction":0.006622516556291391},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GABRA5","total_profiled":1310},"omim":[{"mim_id":"618559","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79; DEE79","url":"https://www.omim.org/entry/618559"},{"mim_id":"618557","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78; DEE78","url":"https://www.omim.org/entry/618557"},{"mim_id":"608636","title":"CHROMOSOME 15q11-q13 DUPLICATION SYNDROME","url":"https://www.omim.org/entry/608636"},{"mim_id":"607952","title":"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 11; SLC6A11","url":"https://www.omim.org/entry/607952"},{"mim_id":"600233","title":"GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-3; GABRG3","url":"https://www.omim.org/entry/600233"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Actin filaments","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":121.7}],"url":"https://www.proteinatlas.org/search/GABRA5"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P31644","domains":[{"cath_id":"2.70.170.10","chopping":"53-255","consensus_level":"high","plddt":93.2592,"start":53,"end":255},{"cath_id":"1.20.58.390","chopping":"258-347_423-449","consensus_level":"high","plddt":93.5585,"start":258,"end":449}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P31644","model_url":"https://alphafold.ebi.ac.uk/files/AF-P31644-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P31644-F1-predicted_aligned_error_v6.png","plddt_mean":81.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GABRA5","jax_strain_url":"https://www.jax.org/strain/search?query=GABRA5"},"sequence":{"accession":"P31644","fasta_url":"https://rest.uniprot.org/uniprotkb/P31644.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P31644/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P31644"}},"corpus_meta":[{"pmid":"29961870","id":"PMC_29961870","title":"De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.","date":"2018","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29961870","citation_count":83,"is_preprint":false},{"pmid":"8388764","id":"PMC_8388764","title":"FISH ordering of reference markers and of the gene for the alpha 5 subunit of the gamma-aminobutyric acid receptor (GABRA5) within the Angelman and Prader-Willi syndrome chromosomal regions.","date":"1993","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8388764","citation_count":76,"is_preprint":false},{"pmid":"7601451","id":"PMC_7601451","title":"The gamma-aminobutyric acid receptor gamma 3 subunit gene (GABRG3) is tightly linked to the alpha 5 subunit gene (GABRA5) on human chromosome 15q11-q13 and is transcribed in the same orientation.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7601451","citation_count":54,"is_preprint":false},{"pmid":"9126483","id":"PMC_9126483","title":"Structure and organization of GABRB3 and GABRA5.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9126483","citation_count":42,"is_preprint":false},{"pmid":"9514592","id":"PMC_9514592","title":"Association between the GABA(A) receptor alpha5 subunit gene locus (GABRA5) and bipolar affective disorder.","date":"1998","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9514592","citation_count":42,"is_preprint":false},{"pmid":"31056671","id":"PMC_31056671","title":"Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.","date":"2019","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31056671","citation_count":36,"is_preprint":false},{"pmid":"37653043","id":"PMC_37653043","title":"Hypothalamic GABRA5-positive neurons control obesity via astrocytic GABA.","date":"2023","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/37653043","citation_count":30,"is_preprint":false},{"pmid":"9267853","id":"PMC_9267853","title":"Positive association between the GABRA5 gene and unipolar recurrent major depression.","date":"1997","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/9267853","citation_count":30,"is_preprint":false},{"pmid":"23516534","id":"PMC_23516534","title":"Hyperpolarization-activated current (In) is reduced in hippocampal neurons from Gabra5-/- mice.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23516534","citation_count":23,"is_preprint":false},{"pmid":"24755890","id":"PMC_24755890","title":"Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder.","date":"2014","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24755890","citation_count":22,"is_preprint":false},{"pmid":"9205108","id":"PMC_9205108","title":"Human gamma-aminobutyric acid-type A receptor alpha5 subunit gene (GABRA5): characterization and structural organization of the 5' flanking region.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9205108","citation_count":19,"is_preprint":false},{"pmid":"9129713","id":"PMC_9129713","title":"Lack of association between juvenile myoclonic epilepsy and GABRA5 and GABRB3 genes.","date":"1997","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9129713","citation_count":12,"is_preprint":false},{"pmid":"16256272","id":"PMC_16256272","title":"Mutations in GABRA1, GABRA5, GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16256272","citation_count":12,"is_preprint":false},{"pmid":"15498372","id":"PMC_15498372","title":"Case-control study and transmission/disequilibrium tests of the genes encoding GABRA5 and GABRB3 in a Chinese population affected by childhood absence epilepsy.","date":"2004","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15498372","citation_count":10,"is_preprint":false},{"pmid":"36120438","id":"PMC_36120438","title":"Gabra5 plays a sexually dimorphic role in POMC neuron activity and glucose balance.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36120438","citation_count":7,"is_preprint":false},{"pmid":"23663378","id":"PMC_23663378","title":"Paradoxical worsening of seizure activity with pregabalin in an adult with isodicentric 15 (IDIC-15) syndrome involving duplications of the GABRB3, GABRA5 and GABRG3 genes.","date":"2013","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23663378","citation_count":7,"is_preprint":false},{"pmid":"34508769","id":"PMC_34508769","title":"Positive modulation of α5GABAA receptors leads to dichotomous effects in rats on memory pattern and GABRA5 expression in prefrontal cortex and hippocampus.","date":"2021","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/34508769","citation_count":7,"is_preprint":false},{"pmid":"32249079","id":"PMC_32249079","title":"A case of GABRA5-related developmental and epileptic encephalopathy with response to a combination of antiepileptic drugs and a GABAering agent.","date":"2020","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/32249079","citation_count":4,"is_preprint":false},{"pmid":"22677273","id":"PMC_22677273","title":"Gabra5-gene haplotype block associated with behavioral properties of the full agonist benzodiazepine chlordiazepoxide.","date":"2012","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/22677273","citation_count":4,"is_preprint":false},{"pmid":"36833213","id":"PMC_36833213","title":"Ablation of Gabra5 Influences Corticosterone Levels and Anxiety-like Behavior in Mice.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36833213","citation_count":2,"is_preprint":false},{"pmid":"34530807","id":"PMC_34530807","title":"An association study in the Taiwan Biobank elicits the GABAA receptor genes GABRB3, GABRA5, and GABRG3 as candidate loci for sleep duration in the Taiwanese population.","date":"2021","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/34530807","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11173,"output_tokens":1986,"usd":0.031655},"stage2":{"model":"claude-opus-4-6","input_tokens":5300,"output_tokens":2166,"usd":0.120975},"total_usd":0.15263,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"The de novo GABRA5 p.V294L variant produces GABAA receptors (α5β3γ2) that are ~10-fold more sensitive to GABA but exhibit reduced maximal GABA-evoked current due to increased receptor desensitization, establishing a gain-of-function mechanism contributing to early-onset epilepsy.\",\n      \"method\": \"Whole-cell patch-clamp recordings from HEK293T cells expressing recombinant α5β3γ2 GABAA receptors carrying the p.V294L substitution\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro functional reconstitution with disease-associated mutagenesis\",\n      \"pmids\": [\"29961870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"De novo GABRA5 missense variants p.V294F and p.S413F (in transmembrane domains) reduce cell-surface and total receptor expression, alter endoplasmic reticulum processing, impair synaptic clustering, reduce GABAA receptor function, and decrease GABA binding potency when incorporated into α5β3γ2 receptors.\",\n      \"method\": \"Whole-cell patch-clamp electrophysiology, immunofluorescence receptor clustering assays, and biochemical analysis of ER processing in neuronal and non-neuronal cells expressing mutant α5 subunits\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (electrophysiology, cell biology, biochemistry) in a single rigorous study\",\n      \"pmids\": [\"31056671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GABRA5-positive neurons in the lateral hypothalamic area (LHA) polysynaptically project to brown and white adipose tissues; chemogenetic inhibition of these neurons suppresses fat thermogenesis and increases weight gain, while gene silencing of GABRA5 in LHA decreases weight gain. In diet-induced obesity, these neurons are tonically inhibited by nearby reactive astrocytes that release GABA synthesized via monoamine oxidase B (Maob).\",\n      \"method\": \"Chemogenetic (DREADD) manipulation, anterograde/retrograde tracing, gene silencing (AAV-shRNA), in vivo electrophysiology, and pharmacological inhibition of Maob in mice\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vivo approaches with defined circuit-level and metabolic phenotypes\",\n      \"pmids\": [\"37653043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Loss of the α5 subunit gene (Gabra5-/-) in mice causes a compensatory ~40% reduction in hyperpolarization-activated cation current (Ih) and a 41% decrease in HCN1 protein expression in hippocampal neurons, indicating homeostatic co-regulation between tonic GABAergic inhibition (α5GABAA receptors) and HCN channels.\",\n      \"method\": \"Whole-cell patch-clamp recordings from cultured embryonic and ex vivo CA1 hippocampal neurons of Gabra5-/- mice; Western blot for HCN1 protein; membrane impedance measurements\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with multiple electrophysiological and biochemical readouts in two neuronal preparations\",\n      \"pmids\": [\"23516534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"POMC neuron-specific knockdown of Gabra5 in male mice increases firing frequency and resting membrane potential of POMC neurons, decreases mIPSC amplitude, and improves glucose tolerance, revealing a sexually dimorphic role of GABRA5 in GABAergic inhibitory control of POMC neurons and glucose homeostasis (effect absent in females).\",\n      \"method\": \"CRISPR-Cas9-mediated POMC-specific gene knockdown; whole-cell patch-clamp electrophysiology of POMC neurons; glucose tolerance tests in male and female mice\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KD with electrophysiological and physiological phenotypes, single study\",\n      \"pmids\": [\"36120438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The GABRA5 gene produces three distinct mRNA isoforms in human brain differing only in the 5' UTR, arising from three alternative first exons (1A, 1B, 1C) driven by distinct promoter elements; CAT reporter assays confirmed promoter activity upstream of each first exon, with expression being tissue- and brain-region-specific.\",\n      \"method\": \"cDNA library screening, 5' RACE, Northern blot, genomic sequencing, CAT reporter assays in transfected cells\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (RACE, Northern blot, reporter assay) in a single study establishing transcriptional regulation\",\n      \"pmids\": [\"9205108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"GABRA5 is encoded by 11 exons spanning ~86 kb on chromosome 15q11-q13, and the GABRG3 gene is located within 35 kb of GABRA5 and transcribed in the same orientation, establishing the physical organization of the GABRA5/GABRG3 cluster.\",\n      \"method\": \"Genomic contig construction (P1, lambda phage, PAC clones), exon mapping, FISH\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct genomic characterization with physical mapping\",\n      \"pmids\": [\"9126483\", \"7601451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Constitutive ablation of Gabra5 in mice leads to a hyperpolarized state of hippocampal neurons (measured by electrophysiology), suggesting compensatory upregulation of other channels or GABA receptor subunits, and is accompanied by decreased fecal corticosterone metabolites, linking GABRA5 to HPA axis activity.\",\n      \"method\": \"Whole-cell electrophysiological recordings from hippocampal neurons of Gabra5 knockout mice; fecal corticosterone metabolite measurements; behavioral testing\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single study with limited mechanistic follow-up on compensation mechanism\",\n      \"pmids\": [\"36833213\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABRA5 encodes the α5 subunit of GABAA receptors, a ligand-gated chloride channel that mediates tonic GABAergic inhibition; disease-associated mutations alter receptor desensitization, surface trafficking, and GABA sensitivity, while the α5-containing receptor also engages in homeostatic co-regulation with HCN channels in hippocampal neurons and, in the lateral hypothalamus, GABRA5-positive neurons receive astrocyte-derived (MAO-B-synthesized) GABA inhibition to control adipose thermogenesis and body weight.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GABRA5 encodes the α5 subunit of GABAA receptors, which assembles into α5β3γ2 pentameric ligand-gated chloride channels that mediate tonic GABAergic inhibition in the brain and regulate neuronal excitability, metabolic homeostasis, and adipose tissue thermogenesis. Disease-associated missense mutations in transmembrane domains (e.g., p.V294L, p.V294F, p.S413F) alter GABA sensitivity, receptor desensitization, endoplasmic reticulum processing, cell-surface trafficking, and synaptic clustering, establishing both gain- and loss-of-function mechanisms contributing to early-onset epilepsy [PMID:29961870, PMID:31056671]. Genetic ablation of Gabra5 in mice triggers homeostatic compensation including a ~40% reduction in HCN1-mediated Ih current in hippocampal neurons, demonstrating co-regulation between tonic GABAergic and hyperpolarization-activated cation conductances [PMID:23516534]. In the lateral hypothalamic area, GABRA5-positive neurons polysynaptically innervate adipose tissue to control thermogenesis and body weight, and are tonically inhibited by astrocyte-derived GABA synthesized via monoamine oxidase B during diet-induced obesity [PMID:37653043].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing the genomic architecture of GABRA5 — its 11-exon structure, chromosomal location at 15q11-q13, proximity to GABRG3, and three alternative 5′ UTR isoforms driven by distinct promoters — provided the foundational gene model and explained tissue- and brain-region-specific transcriptional regulation.\",\n      \"evidence\": \"Genomic contig construction, exon mapping, FISH, 5′ RACE, Northern blot, and CAT reporter assays in human brain and transfected cells\",\n      \"pmids\": [\"9126483\", \"7601451\", \"9205108\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Which transcription factors drive the three alternative promoters remains undefined\",\n        \"Protein-level confirmation of isoform-specific expression in brain subregions was not performed\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating that Gabra5 knockout mice exhibit compensatory downregulation of HCN1 and reduced Ih in hippocampal neurons established that α5-containing GABAA receptors and HCN channels are homeostatically co-regulated, revealing a mechanism by which tonic inhibition is coupled to intrinsic neuronal excitability.\",\n      \"evidence\": \"Whole-cell patch-clamp recordings from cultured embryonic and ex vivo CA1 hippocampal neurons of Gabra5−/− mice; Western blot for HCN1 protein\",\n      \"pmids\": [\"23516534\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The signaling pathway linking loss of α5-mediated tonic inhibition to HCN1 downregulation is unknown\",\n        \"Whether this co-regulation occurs in brain regions beyond hippocampus is untested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Functional characterization of the epilepsy-associated p.V294L variant revealed a gain-of-function mechanism — increased GABA sensitivity coupled with enhanced desensitization — providing the first direct link between a specific GABRA5 mutation and altered channel gating in disease.\",\n      \"evidence\": \"Whole-cell patch-clamp recordings from HEK293T cells expressing recombinant α5β3γ2 GABAA receptors with the p.V294L substitution\",\n      \"pmids\": [\"29961870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo neuronal consequences of V294L on network excitability were not tested\",\n        \"Whether enhanced desensitization leads to net loss or gain of tonic inhibition in intact circuits is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Characterization of additional epilepsy-associated variants (p.V294F, p.S413F) showed that transmembrane domain mutations can impair receptor biogenesis at the ER level, reduce surface expression and synaptic clustering, and decrease GABA potency, establishing loss-of-function as a second disease mechanism complementary to the gain-of-function V294L.\",\n      \"evidence\": \"Whole-cell patch-clamp electrophysiology, immunofluorescence clustering assays, and biochemical ER processing analysis in neuronal and non-neuronal cells\",\n      \"pmids\": [\"31056671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for differential effects of V294L versus V294F on gating versus trafficking is not resolved\",\n        \"Patient-derived neuronal models have not been used to validate these findings\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"POMC neuron-specific knockdown of Gabra5 increased firing rate and improved glucose tolerance in male but not female mice, revealing a sexually dimorphic metabolic role for α5-mediated inhibition in hypothalamic energy-sensing circuits.\",\n      \"evidence\": \"CRISPR-Cas9-mediated POMC-specific knockdown; patch-clamp electrophysiology of POMC neurons; glucose tolerance tests in both sexes\",\n      \"pmids\": [\"36120438\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single study; independent replication is needed\",\n        \"Molecular basis of sex-specific effects is unexplored\",\n        \"Whether this reflects α5-specific tonic inhibition versus compensation by other subunits is unclear\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of GABRA5-positive lateral hypothalamic neurons that polysynaptically control adipose thermogenesis — and are tonically silenced by astrocyte-derived GABA via MAO-B in obesity — established a brain-to-fat circuit through which α5-containing receptors regulate whole-body energy expenditure.\",\n      \"evidence\": \"Chemogenetic (DREADD) manipulation, anterograde/retrograde neural tracing, AAV-shRNA gene silencing, in vivo electrophysiology, and MAO-B pharmacological inhibition in mice\",\n      \"pmids\": [\"37653043\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether this circuit is conserved in humans is unknown\",\n        \"The specific GABAA receptor subunit composition on these LHA neurons beyond α5 has not been defined\",\n        \"Downstream signaling from LHA GABRA5 neurons to adipose sympathetic outflow is not fully mapped\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for how different transmembrane domain mutations produce opposite functional outcomes (gain- versus loss-of-function), whether the α5/HCN1 homeostatic axis operates through a defined signaling intermediate, and how the metabolic functions of GABRA5 in hypothalamic circuits integrate with its well-characterized role in hippocampal tonic inhibition.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of α5-containing GABAA receptors with disease mutations\",\n        \"Signaling pathway linking α5-mediated tonic inhibition to HCN1 expression is undefined\",\n        \"Human relevance of LHA and POMC neuron GABRA5 metabolic circuits is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1, 3, 4]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\n      \"α5β3γ2 GABAA receptor\"\n    ],\n    \"partners\": [\n      \"GABRB3\",\n      \"GABRG2\",\n      \"HCN1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}